Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» PEGPH20
PEGPH20
Halozyme to Restructure After Pancreatic Cancer Drug Fails in Phase 3; 55% of Workforce to be Cut
Xconomy
Mon, 11/4/19 - 10:42 am
Halozyme Therapeutics
pancreatic cancer
clinical trials
restructuring
layoffs
PEGPH20
Halozyme drops PFS co-primary endpoint from PEGPH20 phase 3
Fierce Biotech
Tue, 11/27/18 - 11:35 pm
Halozyme
clinical trials
PEGPH20
metastatic prostate cancer
Halozyme Cancer Drug Does Well in Phase 2
Investopedia
Fri, 01/6/17 - 10:13 am
Halozyme
pancreatic cancer
clinical trials
PEGPH20
Eli Lilly
Celgene
gemcitabine
Abraxane
Why Shares of Halozyme Therapeutics Inc. Plunged 24% in August
Motley Fool
Sun, 09/13/15 - 11:55 am
Halozyme
PEGPH20
AbbVie
Eisai and Halozyme Sign Collaboration Agreement to Investigate Halaven® (Eribulin) and PEGPH20 in Metastatic Breast Cancer
Yahoo
Sat, 08/1/15 - 10:04 am
Eisai
Halozyme
metastatic breast cancer
PEGPH20
Halaven
Halozyme Phase 2 Clinical Study Of Investigational Drug PEGPH20 Shows Doubling Of Progression-free Survival And Improvement Trend In Overall Survival In High HA Metastatic Pancreatic Cancer Patients
Yahoo
Sun, 05/31/15 - 11:57 am
Halozyme
PEGPH20
ASCO
metastatic pancreatic cancer
Halozyme Provides Update Following Type B FDA Meeting
Yahoo
Wed, 04/8/15 - 10:44 am
Halozyme
FDA
PEGPH20
pancreatic cancer
Halozyme's PEGPH20 Study S1313 Clinical Hold Lifted by FDA
Yahoo/Zacks
Sat, 09/20/14 - 08:52 am
Halozyme
PEGPH20
pancreatic cancer
metastatic pancreatic cancer
Halozyme's PEGPH20 Program Gains Fast Track Designation
Yahoo/Zacks
Sat, 09/6/14 - 09:18 am
Halozyme
PEGPH20
metastatic pancreatic cancer
pancreatic cancer
Pancreatic Cancer Trial Enrollment Halt Damages Halozyme
Yahoo/247WallStreet
Fri, 04/4/14 - 09:31 am
Halozyme
pancreatic cancer
PEGPH20
3 Stocks to Watch Ahead of ASCO
Motley Fool
Tue, 05/28/13 - 06:28 pm
cancer
ASCO
nivolumab
Bristol-Myers Squibb
idelalisad
Gilead
PEGPH20
Halozyme
pancreatic cancer
Halozyme rises on pancreatic cancer drug study
Yahoo/AP
Thu, 05/16/13 - 05:30 pm
pancreatic cancer
Halozyme
PEGPH20